Varenicline as a Treatment for Methamphetamine Dependence
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to determine the effects of treatment with varenicline (1
and 2 mg daily), compared to treatment with placebo, on methamphetamine-induced craving and
subjective effects in methamphetamine-dependent human volunteers.